CoChat

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Changes in Insulin Sensitivity and Insulin Release in Relation to Glycemia and Glucose Tolerance in 6,414 Finnish Men

Open access

Abstract

OBJECTIVE: We evaluated insulin sensitivity and insulin secretion across the entire range of fasting (FPG) and 2-h plasma glucose (PG), and we investigated the differences in insulin sensitivity and insulin release in different glucose tolerance categories. RESEARCH DESIGN AND METHODS: A total of 6,414 Finnish men (aged 57 ± 7 years, BMI 27.0 ± 3.9 kg/m2) from our ongoing population-based METSIM (Metabolic Syndrome in Men) study were included. Of these subjects, 2,168 had normal glucose tolerance, 2,859 isolated impaired fasting glucose (IFG), 217 isolated impaired glucose tolerance (IGT), 701 a combination of IFG and IGT, and 469 newly diagnosed type 2 diabetes. RESULTS: The Matsuda index of insulin sensitivity decreased substantially within the normal range of FPG (−17%) and 2-h PG (−37%) and was approximately −65 and −53% in the diabetic range of FPG and 2-h PG, respectively, compared with the reference range (FPG and 2-h PG <5.0 mmol/l). Early-phase insulin release declined by only approximately −5% within the normal range of FPG and 2-h PG but decreased significantly in the diabetic range of FPG (by 32–70%) and 2-h PG (by 33–51%). Changes in insulin sensitivity and insulin secretion in relation to hyperglycemia were independent of obesity. The predominant feature of isolated IGT was impaired peripheral insulin sensitivity. Isolated IFG was characterized by impaired early and total insulin release. CONCLUSIONS: Peripheral insulin sensitivity was already decreased substantially at low PG levels within the normoglycemic range, whereas impairment in insulin secretion was observed mainly in the diabetic range of FPG and 2-h PG. Obesity did not affect changes in insulin sensitivity or insulin secretion in relation to hyperglycemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db08-1607

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Insulin sensitivity (Matsuda ISI) (A and B), early-phase insulin release (InsAUC30/GluAUC30) (C and D), and total insulin release during the OGTT (InsAUC120/GluAUC120) (E and F) across the categories of FPG and 2-h PG. Bars display the value of insulin sensitivity or insulin release relative to the reference category (FPG <5.0 mmol/l, 2-h PG <5.0 mmol/l). Calculations were based on geometric means, adjusted for age and BMI with the general linear model. Cutoff values for different categories of FPG were (in mg/dl): 90.1 (5.0 mmol/l), 99.1 (5.5 mmol/l), 108.1 (6.0 mmol/l), 117.1 (6.5 mmol/l), 126.1 (7.0 mmol/l), 135.1 (7.5 mmol/l), 144.1 (8.0 mmol/l), 153.2 (8.5 mmol/l), and 162.2 (9.0 mmol/l). Cutoff values for different categories of 2-h PG were (in mg/dl): 90.1 (5.0 mmol/l), 108.1 (6.0 mmol/l), 126.1 (7.0 mmol/l), 144.1 (8.0 mmol/l), 162.2 (9.0 mmol/l), 180.2 (10.0 mmol/l), 198.2 (11.0 mmol/l), 216.2 (12.0 mmol/l), and 234.2 (13.0 mmol/l).
FIG. 1. Insulin sensitivity (Matsuda ISI) (A and B), early-phase insulin release (InsAUC30/GluAUC30) (C and D), and total insulin release during the OGTT (InsAUC120/GluAUC120) (E and F) across the categories of FPG and 2-h PG. Bars display the value of insulin sensitivity or insulin release relative to the reference category (FPG <5.0 mmol/l, 2-h PG <5.0 mmol/l). Calculations were based on geometric means, adjusted for age and BMI with the general linear model. Cutoff values for different categories of FPG were (in mg/dl): 90.1 (5.0 mmol/l), 99.1 (5.5 mmol/l), 108.1 (6.0 mmol/l), 117.1 (6.5 mmol/l), 126.1 (7.0 mmol/l), 135.1 (7.5 mmol/l), 144.1 (8.0 mmol/l), 153.2 (8.5 mmol/l), and 162.2 (9.0 mmol/l). Cutoff values for different categories of 2-h PG were (in mg/dl): 90.1 (5.0 mmol/l), 108.1 (6.0 mmol/l), 126.1 (7.0 mmol/l), 144.1 (8.0 mmol/l), 162.2 (9.0 mmol/l), 180.2 (10.0 mmol/l), 198.2 (11.0 mmol/l), 216.2 (12.0 mmol/l), and 234.2 (13.0 mmol/l).CC BY-NC-ND · PubMed Central
FIG. 2. Disposition indexes corresponding to early-phase (DI30 = Matsuda ISI × InsAUC30/GluAUC30) and total insulin release (DI120 = Matsuda ISI × InsAUC120/GluAUC120) across the categories of FPG (A) and 2-h PG (B). Cutoff values for different categories of FPG and 2-h PG are as explained in Fig. 1.
FIG. 2. Disposition indexes corresponding to early-phase (DI30 = Matsuda ISI × InsAUC30/GluAUC30) and total insulin release (DI120 = Matsuda ISI × InsAUC120/GluAUC120) across the categories of FPG (A) and 2-h PG (B). Cutoff values for different categories of FPG and 2-h PG are as explained in Fig. 1.CC BY-NC-ND · PubMed Central
FIG. 3. Insulin sensitivity (Matsuda ISI) (A and B), early-phase insulin release (InsAUC30/GluAUC30) (C and D), and total insulin release in an OGTT (InsAUC120/GluAUC120) (E and F) across the categories of FPG and 2-h PG in nonobese (BMI <27 kg/m2; ▲) and obese subjects (BMI ≥27 kg/m2; ■). Bars display insulin sensitivity or insulin release relative to the reference category (FPG <5.0 mmol/l, 2-h PG <5.0 mmol/l). Calculations were based on geometric means, adjusted for age and BMI, with the general linear model (performed separately in subgroups of nonobese and obese subjects). Cutoff values for different categories of FPG and 2-h PG are as explained in Fig. 1. Ref., reference.
FIG. 3. Insulin sensitivity (Matsuda ISI) (A and B), early-phase insulin release (InsAUC30/GluAUC30) (C and D), and total insulin release in an OGTT (InsAUC120/GluAUC120) (E and F) across the categories of FPG and 2-h PG in nonobese (BMI <27 kg/m2; ▲) and obese subjects (BMI ≥27 kg/m2; ■). Bars display insulin sensitivity or insulin release relative to the reference category (FPG <5.0 mmol/l, 2-h PG <5.0 mmol/l). Calculations were based on geometric means, adjusted for age and BMI, with the general linear model (performed separately in subgroups of nonobese and obese subjects). Cutoff values for different categories of FPG and 2-h PG are as explained in Fig. 1. Ref., reference.CC BY-NC-ND · PubMed Central
FIG. 4. Insulin sensitivity (Matsuda ISI and 1/HOMA-IR) (A and B), early-phase insulin release (InsAUC30/GluAUC30) (C), total insulin release (InsAUC120/GluAUC120) (D), disposition index for early insulin release (DI30 = Matsuda ISI × InsAUC30/GluAUC30) (E), and disposition index for total insulin release (DI120 = Matsuda ISI × InsAUC120/GluAUC120) (F) in different categories of glucose tolerance. Bars show percentage of each index relative to NGT (reference, 100%). Calculations were based on geometric means, adjusted for age and BMI (ANCOVA). All pairwise comparisons were statistically significant (P < 0.05, Bonferroni post hoc test) except for those marked: *P > 0.05 vs. NGT, †P > 0.05 vs. isolated IFG, ‡P > 0.05 vs. isolated IGT. Ref., reference. IIFG, isolated IFG; IIGT, isolated IGT; NewDM, newly diagnosed diabetes.
FIG. 4. Insulin sensitivity (Matsuda ISI and 1/HOMA-IR) (A and B), early-phase insulin release (InsAUC30/GluAUC30) (C), total insulin release (InsAUC120/GluAUC120) (D), disposition index for early insulin release (DI30 = Matsuda ISI × InsAUC30/GluAUC30) (E), and disposition index for total insulin release (DI120 = Matsuda ISI × InsAUC120/GluAUC120) (F) in different categories of glucose tolerance. Bars show percentage of each index relative to NGT (reference, 100%). Calculations were based on geometric means, adjusted for age and BMI (ANCOVA). All pairwise comparisons were statistically significant (P < 0.05, Bonferroni post hoc test) except for those marked: *P > 0.05 vs. NGT, †P > 0.05 vs. isolated IFG, ‡P > 0.05 vs. isolated IGT. Ref., reference. IIFG, isolated IFG; IIGT, isolated IGT; NewDM, newly diagnosed diabetes.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Cited by

See all 348

Metadata

Authors
Stančáková, A., Javorský, M., Kuulasmaa, T., Haffner, S. M., Kuusisto, J., & Laakso, M.
Affiliations
  • Kuopio University Hospital (FI)
  • The University of Texas at San Antonio Health Science Center (US)
Corresponding author
Laakso, Markku
Venue
Diabetes
Published
2009-02-17
Volume
58
Issue
5
Pages
1212-1221
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2108628281
Cited by
348
References
47
Citations by year
2026: 6 · 2025: 18 · 2024: 19 · 2023: 21 · 2022: 21 · 2021: 21 · 2020: 22 · 2019: 20 · 2018: 21 · 2017: 36 · 2016: 19 · 2015: 26 · 2014: 23 · 2013: 18 · 2012: 16
FWCI
13.57
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Academy of Finland (124243)
  • Tekes (1510/31/06)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
insulin sensitivity, insulin secretion, glucose tolerance, impaired fasting glucose, impaired glucose tolerance, type 2 diabetes, Matsuda index, hyperglycemia, obesity, men
MeSH terms
Insulin Secretion, Blood Glucose, Cross-Sectional Studies, Finland, Glucose Tolerance Test, Humans, Insulin, Male, Middle Aged, Reference Values, Glucose Intolerance, Area Under Curve, Metabolic Syndrome, Insulin-Secreting Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Changes in Insulin Sensitivity and Insulin Release in Relation to Glycemia and Glucose Tolerance in 6,414 Finnish Men. https://app.cochat.ai/papers/10.2337/db08-1607
The paper
Stančáková, A., Javorský, M., Kuulasmaa, T., Haffner, S. M., Kuusisto, J., & Laakso, M. (2009). Changes in Insulin Sensitivity and Insulin Release in Relation to Glycemia and Glucose Tolerance in 6,414 Finnish Men. Diabetes. https://doi.org/10.2337/db08-1607

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.